β-hydroxybutyrate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for β-hydroxybutyrate, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer [Phase 2]